EUCTR2021-001769-19-SE进行中（未招募）1 期
Immune response to SARS-CoV-2 in health care workers, previously infected subjects, and immunocompromised subjects, before and after Covid-19 vaccination: a phase IV trial
GUVAX (Gothenburg University Vaccine Research Institute)0 个研究点目标入组 1,200 人开始时间: 2021年3月29日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Provided written informed consent
- •Vaccinated against SARS-CoV-2
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 900
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 300
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
SARS-CoV-2 immune responseimmune response to COVDI-19 vaccinationEUCTR2021-001202-30-NLDiakonessenhuis400
招募中
不适用
SARS-CoV-2 immune responseCOVID-1910047438NL-OMON55057Diakonessenhuis Utrecht800
已完成
不适用
Immune response against SARS-CoV-2 vaccinatioCOVID-19DRKS00028174DKFZ6
已完成
不适用
Immune response to COVID-19 vaccination in patients with autoimmune disorders on various types of immunosuppressive treatmentsImmune response to COVID-19 (SARS-CoV-2 infection) vaccination in patients on immunosuppressive therapyInfections and InfestationsISRCTN68832164Charles University199
招募中
不适用
SARS-CoV-2-IgG-titer of antibodies in helathcare workers after recovery or vaccinatio07.1 COVID-19DRKS00026288Evangelische Kliniken Gelsenkirchen800